Specific considerations with the automatic implantable atrial defibrillator

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• Internal atrial defibrillation has been explored for over 20 years as an alternative to external methods.
• Studies demonstrate the feasibility of internal atrial defibrillation with low energy requirements.
• This has led to the development of the implantable atrial defibrillator (IAD).

Purpose of the Study:

• To evaluate the safety, efficacy, and tolerability of the Metrix system for internal atrial defibrillation.
• To assess the potential of IAD as a therapeutic alternative for specific atrial fibrillation (AF) patient subgroups.
• To determine if IAD can maintain sinus rhythm or prolong arrhythmia-free intervals.

Main Methods:

• Clinical experience with the Metrix system was assessed.
• Key metrics included atrial defibrillation thresholds, R wave synchronization, and detection of atrial fibrillation (AF).
• Evaluation focused on shock-induced proarrhythmia and patient tolerability.

Main Results:

• The Metrix system demonstrated stable atrial defibrillation thresholds and appropriate R wave synchronization.
• Excellent detection of atrial fibrillation (AF) with 100% specificity was observed.
• No shock-induced ventricular proarrhythmia was reported with correctly synchronized low-energy shocks.

Conclusions:

• The implantable atrial defibrillator (IAD) may be a viable option for patients with drug-refractory, symptomatic, infrequent atrial fibrillation (AF).
• Further research is needed to enhance patient comfort and increase the acceptability of internal atrial defibrillation.
• The Metrix system shows potential as a therapeutic alternative for a specific AF patient population.